AQR Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.82M | Sell |
214,650
-288,893
| -57% | -$2.45M | ﹤0.01% | 1837 |
|
2025
Q1 | $4.05M | Buy |
503,543
+40,380
| +9% | +$325K | ﹤0.01% | 1234 |
|
2024
Q4 | $4.16M | Sell |
463,163
-105,155
| -19% | -$944K | 0.01% | 1179 |
|
2024
Q3 | $4.17M | Buy |
568,318
+366,077
| +181% | +$2.68M | 0.01% | 1142 |
|
2024
Q2 | $1.15M | Buy |
+202,241
| New | +$1.15M | ﹤0.01% | 1686 |
|
2024
Q1 | – | Sell |
-21,435
| Closed | -$193K | – | 2415 |
|
2023
Q4 | $193K | Buy |
21,435
+2,829
| +15% | +$25.4K | ﹤0.01% | 2223 |
|
2023
Q3 | $145K | Buy |
18,606
+7,446
| +67% | +$57.9K | ﹤0.01% | 2185 |
|
2023
Q2 | $108K | Sell |
11,160
-12,454
| -53% | -$121K | ﹤0.01% | 2141 |
|
2023
Q1 | $259K | Buy |
23,614
+11,658
| +98% | +$128K | ﹤0.01% | 1984 |
|
2022
Q4 | $51.7K | Buy |
+11,956
| New | +$51.7K | ﹤0.01% | 2169 |
|